This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Anaxis Pharma Pty Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Peter Edward Czabotar
Introduction
Peter Edward Czabotar is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sulphonamide compounds. His work focuses on innovative solutions for treating complex medical conditions.
Latest Patents
Czabotar holds a patent for sulphonamide compounds, which relates to compounds of formula (I) and includes salts, solvates, tautomers, N-oxides, stereoisomers, polymorphs, and/or prodrugs thereof. This invention is particularly relevant for its application in treating necroptosis and inhibiting MLKL, showcasing his commitment to advancing medical science.
Career Highlights
Czabotar is associated with Anaxis Pharma Pty Ltd, where he continues to push the boundaries of pharmaceutical research. His work has led to the development of innovative compounds that have the potential to improve patient outcomes in various medical scenarios.
Collaborations
He collaborates with esteemed colleagues such as Angus Cowan and John Thomas Feutrill, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Peter Edward Czabotar's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key figure in advancing medical research. His work continues to inspire future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile